Navigation Links
MedImmune Announces Seven Key Promotions and New Hires
Date:11/5/2007

GAITHERSBURG, Md., Nov. 5 /PRNewswire/ -- MedImmune, Inc. today announced that it has made several new senior appointments across the organization. Alexander A. Zukiwski, M.D., senior vice president, clinical research; Timothy J. Hahn, Ph.D., vice president, antibody manufacturing; and Timothy J. Maines, vice president, corporate quality assurance have recently joined the company. In addition, new executive promotions include Max Donley, vice president, human resources; Jonathan Klein-Evans, J.D., vice president, intellectual property; Timothy Pearson, vice president & chief financial officer; and Paul Williams, vice president, sales operations.

"As MedImmune transitions into its new role as the global biologics unit of AstraZeneca, it is imperative to strengthen the company's leadership platform across all facets of our business. Alex, Tim Hahn and Tim Maines add an additional depth of expertise in the areas of clinical research, antibody manufacturing, and quality assurance, respectively, which are each critical to our ability to deliver new drugs to patients in need," said David M. Mott, chief executive officer and president. "The new vice presidential appointments of Max, Jonathan, Tim Pearson and Paul foster MedImmune's ability to continue to recruit and grow talent, protect our intellectual properties, manage our financial reporting obligations to AstraZeneca plc (our parent company) and serve our customers to the highest possible standards."

New Leadership

As the newest senior addition, Dr. Alexander Zukiwski joins MedImmune as senior vice president, clinical research, where he will be responsible for shaping and overseeing the company's strategy for clinical trials of its drug candidates. Prior to joining the company, Dr. Zukiwski held several roles of increasing responsibility in support of Johnson & Johnson's (J&J) medical affairs and clinical development functions at Johnson & Johnson Pharmaceutical Research & Development, LLC (J&
'/>"/>

SOURCE MedImmune, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
2. MedImmune Celebrates Opening of New Pilot Lab at Gaithersburg Headquarters
3. MedImmune Recognized by Local Volunteer Organization for Its Employees Exceptional Commitment to Community Service within Montgomery County
4. MedImmune to Present RSV Surveillance and Cost-Effectiveness Data at American Academy of Pediatrics National Conference & Exhibition
5. AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
8. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
9. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... VIA Pharmaceuticals, In...ed on the development of compounds for the treatme...announced that it has completed the last patient v...2291. ,, The FDG-PET trial enrolled 52 patient...Canada including Massachusetts General Hospital, M...
(Date:12/3/2009)...3 Inverness Medical Inno...nabling individuals to take charge of their health...nd health management, has declared a dividend of $...al Preferred Stock ( IMA-PB). The dividend will be... share equal to the quotient of (a) $3.00 divided ...
(Date:12/2/2009)...2 Martek Biosciences Cor...intends to release the results of its fourth quart...pproximately 4:00 p.m. Eastern Time (ET). Followi...t a conference call to discuss these results with ...he call live via webcast by visiting Martek,s web ...
(Date:12/2/2009)...2 Reportlinker.com announces that ...atalogue: ,, Carbondioxide Incubators - A Glob...ker.com/p0164368/Carbondioxide-Incubators---A-Glob...the most critical equipment used in microbiology, ... for providing a controlled environment to grow an...
Breaking Biology Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4
... to create an early healthcare model should be enh...ition of Abbott Laboratories, in-vitro diagnosti...ccording to GE executives. , ,GE and Abbott annou...ement for GE, the parent GE Healthcare, to acquire... units for $8.13 billion in cash. , ,The transacti...
...Wisconsin , in response to the federal government,...a five-year, $8.1 million federal grant to develop...avian flu and the majority of potential bioterrori... National Institutes of Health,s Institute of Alle...lop a device that would be used in outpatient sett...
...elphi Group, a Boston-based consultancy focused on...Perot Systems, Innovation Lab. He will arrive in M...usion 2007 CEO-CIO Symposium . We asked him to sha... information technology professionals can work tog...ideal situation for IT working with business proce...
Other Biology Technology:GE acquisition may boost "early" healthcare strategy 2Medical College lands $8.1M grant to detect bird flu, bioterror agents 2Innovation expert speaks on the business-IT balancing act 2Innovation expert speaks on the business-IT balancing act 3Innovation expert speaks on the business-IT balancing act 4Innovation expert speaks on the business-IT balancing act 5
(Date:12/2/2009)...f, peanut butter, and other foods have done more t...safety. They also are quietly fueling a boom in th...new food safety regulations. That,s the topic of t...hemical & Engineering News , (C&EN) ACS, weekly ne...ley and Senior Correspondent Marc Reisch point out...
(Date:12/2/2009)...ring a cap is good for you, at least if you are a ...s Engineering in Oncology Center have shown that i...bers holds the cell,s nucleus, its genetic storeho... influence on cell and nuclear shape, the research...treatment of diseases such as cancer, muscular dys...
(Date:12/2/2009)...OOD SHORES, Calif. and PALM HARBOR, Fla., Dec. 2 /...e Corporation ("CIC") (OTC Bulletin Board: CICI), ...ns for business process automation in the financia...ic signature verification and Docubase Systems Inc... Document Management (EDM) software provider annou...
Breaking Biology News(10 mins):A cell's 'cap' of bundled fibers could yield clues to disease 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4UCR plant scientists research spawns new discoveries showing how crops survive drought 10793 1UCR plant scientists research spawns new discoveries showing how crops survive drought 10793 2UCR plant scientists research spawns new discoveries showing how crops survive drought 10793 3UCR plant scientists research spawns new discoveries showing how crops survive drought 10793 4ACCSC Grants Catherine Hinds Institute of Esthetics a Distinguished School of Excellence Award Award Recognizes High Level Achievements of Students 61638 1ACCSC Grants Catherine Hinds Institute of Esthetics a Distinguished School of Excellence Award Award Recognizes High Level Achievements of Students 61638 2ACCSC Grants Catherine Hinds Institute of Esthetics a Distinguished School of Excellence Award Award Recognizes High Level Achievements of Students 61638 3Study Shows Hospital Report Cards Unlikely to Spur Improvement 61636 1Study Shows Hospital Report Cards Unlikely to Spur Improvement 61636 2
...nadian and U.S. researchers have made a surprising...cks are surviving in rivers with hydroelectric dam.... , This is the first study of its kind and is c...that includes researchers from the University of B... October 28 issue of the open access journal PLoS...
...his release is available in French . , A McGil...a $100,000 grant from the Gates Foundation to help...rch programs in Botswana and South Africa. , "Pe...stry doesn,t do very much work on diseases of the ... Geary, of McGill,s Institute of Parasitology. "Th...
...WEST LAFAYETTE, Ind. - Earthworms can change the c...est litter and soils, potentially affecting the am...due University researchers. , The Purdue scientis...Institution and Johns Hopkins University, study th... America from Europe. They want to determine the e...
Other Biology News:Similar survival rates for Pacific salmon in Fraser, Columbia Rivers raises new questions 2Boost from McGill, Gates Foundation helps Africans control pharma research 2Earthworm activity can alter forests' carbon-carrying capabilities 2Earthworm activity can alter forests' carbon-carrying capabilities 3
Mouse Anti-Hamartin Monoclonal Antibody, Unconjugated, Clone 1B2 from Cell Signaling Technology
Blank Calibration Particles, 3.0-3.4 mu m from BD Biosciences Pharmingen
Rabbit Anti-Human SYT16 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Anti-IL-12 / IL-23 Monoclonal Antibody, Alexa Fluor 647 Conjugated, Clone C17.8 from eBioscience
Biology Products: